{"id":"https://openalex.org/W2005105789","doi":"https://doi.org/10.1002/ddr.10382","title":"Characterization of the anti\u2010platelet actions of FK419, a novel non\u2010peptide antagonist of platelet GPIIb/IIIa","display_name":"Characterization of the anti\u2010platelet actions of FK419, a novel non\u2010peptide antagonist of platelet GPIIb/IIIa","publication_year":2004,"publication_date":"2004-04-01","ids":{"openalex":"https://openalex.org/W2005105789","doi":"https://doi.org/10.1002/ddr.10382","mag":"2005105789"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.10382","doi":"https://doi.org/10.1002/ddr.10382","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.10382","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.10382","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.10382","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084968109","display_name":"Kayoko Mihara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kayoko Mihara","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106084726","display_name":"Toshiaki Aoki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiaki Aoki","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061419966","display_name":"Akira Moriguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akira Moriguchi","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103162834","display_name":"Hiroko Yamamoto","orcid":"https://orcid.org/0000-0001-9241-3870","observed_orcids":["https://orcid.org/0000-0001-9241-3870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroko Yamamoto","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112341733","display_name":"Masashi Maeda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masashi Maeda","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089207012","display_name":"Nobuteru Tojo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuteru Tojo","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshio Yamanaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Yamanaka","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109428081","display_name":"Mitsuru Ohkubo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitsuru Ohkubo","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100865618","display_name":"Nobuya Matsuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuya Matsuoka","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103462024","display_name":"Jiro Seki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiro Seki","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076947182","display_name":"Seitaro Mutoh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seitaro Mutoh","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5084968109"],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":1.0596,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.77003185,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"61","issue":"4","first_page":"233","last_page":"241"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.06400000303983688,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonpeptide-antagonists","display_name":"non-peptide antagonists","score":0.6069999933242798},{"id":"https://openalex.org/keywords/gp-iib-iiia","display_name":"GPIIb/IIIa","score":0.828000009059906},{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.8500000238418579},{"id":"https://openalex.org/keywords/platelet-inhibition","display_name":"platelet aggregation inhibition","score":0.9620000123977661},{"id":"https://openalex.org/keywords/tirofiban","display_name":"tirofiban","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.9190000295639038},{"id":"https://openalex.org/keywords/thrombotic-disorders","display_name":"thrombotic disorders","score":0.8169999718666077},{"id":"https://openalex.org/keywords/receptor-binding","display_name":"receptor binding","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.7837961912155151},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7240455746650696},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7110370397567749},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6985652446746826},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.6754364371299744},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6601701974868774},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5268660187721252},{"id":"https://openalex.org/C2776335557","wikidata":"https://www.wikidata.org/wiki/Q415366","display_name":"Tirofiban","level":4,"score":0.5242804884910583},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.4841228425502777},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.46874764561653137},{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.44869330525398254},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.41602906584739685},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.367051362991333},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28106552362442017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1842668652534485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16631555557250977},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11571544408798218},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.0},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.10382","doi":"https://doi.org/10.1002/ddr.10382","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.10382","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.10382","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1002/ddr.10382","doi":"https://doi.org/10.1002/ddr.10382","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.10382","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.10382","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005105789.pdf","grobid_xml":"https://content.openalex.org/works/W2005105789.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W74808756","https://openalex.org/W1518372943","https://openalex.org/W1602418150","https://openalex.org/W1964772304","https://openalex.org/W1965423095","https://openalex.org/W1965760021","https://openalex.org/W1981038529","https://openalex.org/W1982484709","https://openalex.org/W2012330153","https://openalex.org/W2026624464","https://openalex.org/W2030665169","https://openalex.org/W2043503971","https://openalex.org/W2070707394","https://openalex.org/W2076780074","https://openalex.org/W2078603251","https://openalex.org/W2087192520","https://openalex.org/W2087632380","https://openalex.org/W2137499117","https://openalex.org/W2165207329","https://openalex.org/W2230724256","https://openalex.org/W2230838014","https://openalex.org/W2319834083","https://openalex.org/W2408431202","https://openalex.org/W3022148767","https://openalex.org/W4247822158","https://openalex.org/W4252170135","https://openalex.org/W4285719527","https://openalex.org/W4324113931"],"related_works":["https://openalex.org/W2032929395","https://openalex.org/W2112117810","https://openalex.org/W2099045949","https://openalex.org/W1602418150","https://openalex.org/W1974831463","https://openalex.org/W2095858622","https://openalex.org/W2316521435","https://openalex.org/W1980447920","https://openalex.org/W1988714833","https://openalex.org/W2068916210"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"anti\u2010platelet":[2,76,150],"properties":[3],"of":[4,19,54,64],"FK419":[5,43,57,71,108,127],"((S)\u20102\u2010acetylamino\u20103\u2010[(R)\u2010[1\u2010[3\u2010(piperidin\u20104\u2010yl)propionyl]piperidin\u20103\u2010ylcarbonyl]":[6],"amino]propionic":[7],"acid),":[8],"a":[9,17,129,148],"novel":[10],"non\u2010peptide":[11],"GPIIb/IIIa":[12,30,46,134],"antagonist,":[13],"were":[14],"compared":[15],"in":[16,23,26,73,81,84,98,121,141],"variety":[18],"experimental":[20],"settings,":[21],"both":[22],"vitro":[24,74],"and":[25,36,91,100,132],"vivo,":[27,142],"with":[28,52,78],"other":[29,106],"antagonists":[31],"including":[32],"xemilofiban,":[33],"lamifiban,":[34],"tirofiban,":[35],"FK633.":[37],"Receptor":[38],"binding":[39],"studies":[40],"suggested":[41],"that":[42,49,116,126,136,144],"had":[44],"potent":[45],"antagonistic":[47],"activity":[48],"is":[50,128],"comparable":[51],"those":[53],"reference":[55],"antagonists.":[56],"effectively":[58],"inhibited":[59,93,118],"human":[60,82],"platelet":[61,96,119,139],"aggregation,":[62],"regardless":[63],"agonist":[65],"stimuli":[66],"(IC50":[67],"=":[68],"35\u2013170":[69],"nM).":[70],"demonstrated":[72],"species\u2010dependent":[75],"activity,":[77],"higher":[79],"potency":[80],"than":[83],"dog,":[85],"guinea":[86,101],"pig,":[87],"or":[88],"rat":[89],"tissue,":[90],"dose\u2010dependently":[92],"ex":[94],"vivo":[95],"aggregation":[97,120,140],"dogs":[99],"pigs.":[102],"In":[103],"contrast":[104],"to":[105],"antagonists,":[107],"minimally":[109],"affected":[110],"template":[111],"bleeding":[112],"time":[113],"at":[114],"doses":[115],"completely":[117],"canines.":[122],"These":[123],"results":[124],"demonstrate":[125],"novel,":[130],"potent,":[131],"selective":[133],"antagonist":[135],"safely":[137],"inhibits":[138],"suggesting":[143],"it":[145],"may":[146],"be":[147],"promising":[149],"agent":[151],"for":[152],"thrombotic":[153],"diseases.":[154],"Drug":[155],"Dev.":[156],"Res.":[157],"61:233\u2013241,":[158],"2004.":[159],"\u00a9":[160],"2004":[161],"Wiley\u2010Liss,":[162],"Inc.":[163]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}